Amgen to Acquire BioVex, a Privately Held Biotechnology Company Headquartered … – PR Newswire (press release)
By Dr. Matthew Watson
 Genetic Engineering News | Amgen to Acquire BioVex, a Privately Held Biotechnology Company Headquartered ... PR Newswire (press release) A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bringing safe, effective medicines from lab ... Amgen to acquire BioVex Group Inc for up to $1 billiondomain-B Boost for Europe venture capital after BioVex dealFinancial Times Amgen 4Q profit rises, buys cancer drug makerThe Associated Press BusinessWeek -Bloomberg -AltAssets all 243 news articles » |
Uncategorized
Comments Off on Amgen to Acquire BioVex, a Privately Held Biotechnology Company Headquartered … – PR Newswire (press release) |
January 26th, 2011
This author published 5912 posts in this site.Share
Comments are closed.
Personalized Gene Medicine
| Mesenchymal Stem Cells
| Stem Cell Treatment for Multiple Sclerosis
| Stem Cell Treatments
| Board Certified Stem Cell Doctors
| Stem Cell Medicine
| Personalized Stem Cells Therapy
| Stem Cell Therapy TV
| Individual Stem Cell Therapy
| Stem Cell Therapy Updates
| MD Supervised Stem Cell Therapy
| IPS Stem Cell Org
| IPS Stem Cell Net
| Genetic Medicine
| Gene Medicine
| Longevity Medicine
| Immortality Medicine
| Nano Medicine
| Gene Therapy MD
| Individual Gene Therapy
| Affordable Stem Cell Therapy
| Affordable Stem Cells
| Stem Cells Research
| Stem Cell Breaking Research